▶ 調査レポート

世界のフルララネルAPI市場 2028年:最小95%、最小98%

• 英文タイトル:Global Fluralaner API Market Insights, Forecast to 2028

Global Fluralaner API Market Insights, Forecast to 2028「世界のフルララネルAPI市場 2028年:最小95%、最小98%」(市場規模、市場予測)調査レポートです。• レポートコード:QY2207C0463
• 出版社/出版日:QYResearch / 2022年7月15日
• レポート形態:英文、PDF、94ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:化学&材料
• 販売価格(消費税別)
  Single User¥725,200 (USD4,900)▷ お問い合わせ
  Multi User¥1,087,800 (USD7,350)▷ お問い合わせ
  Enterprise License¥1,450,400 (USD9,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
新型コロナウイルス感染症のパンデミックにより、世界のフルララネルAPIの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx%で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にフルララネルAPIの世界市場のxxx%を占める「最小95%」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx%CAGRで成長すると予測されています。一方、「経口薬」セグメントは、この予測期間を通じてxxx%のCAGRに変更されます。
中国のフルララネルAPIの市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのフルララネルAPI市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx%であり、中国とヨーロッパはそれぞれxxx%とxxx%です。中国の割合は2028年にxxx%に達し、対象期間を通じてxxx%のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx%、xxx%、xxx%になる見通しです。ヨーロッパのフルララネルAPI市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx%になる見通しです。

フルララネルAPIのグローバル主要メーカーには、HIKAL Ltd.、Nissan Chemical、HuBei Masteam Bio-tech、Shaanxi Dideu Group、Hunan Huateng Pharmaceutical、Hebei Lingding Biotechnology、Zhejiang Gihi Chemicals、Xiamen Sinoway Industrialなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx%の市場シェアを占めています。

フルララネルAPI市場は、種類と用途によって区分されます。世界のフルララネルAPI市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年~2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
最小95%、最小98%

【用途別セグメント】
経口薬、外薬

【掲載地域】
北米:アメリカ、カナダ
ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋:日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米:メキシコ、ブラジル、アルゼンチン
中東・アフリカ:トルコ、サウジアラビア、UAE

【目次(一部)】

・調査の範囲
- フルララネルAPI製品概要
- 種類別市場(最小95%、最小98%)
- 用途別市場(経口薬、外薬)
- 調査の目的
・エグゼクティブサマリー
- 世界のフルララネルAPI販売量予測2017-2028
- 世界のフルララネルAPI売上予測2017-2028
- フルララネルAPIの地域別販売量
- フルララネルAPIの地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別フルララネルAPI販売量
- 主要メーカー別フルララネルAPI売上
- 主要メーカー別フルララネルAPI価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模(最小95%、最小98%)
- フルララネルAPIの種類別販売量
- フルララネルAPIの種類別売上
- フルララネルAPIの種類別価格
・用途別市場規模(経口薬、外薬)
- フルララネルAPIの用途別販売量
- フルララネルAPIの用途別売上
- フルララネルAPIの用途別価格
・北米市場
- 北米のフルララネルAPI市場規模(種類別、用途別)
- 主要国別のフルララネルAPI市場規模(アメリカ、カナダ)
・ヨーロッパ市場
- ヨーロッパのフルララネルAPI市場規模(種類別、用途別)
- 主要国別のフルララネルAPI市場規模(ドイツ、フランス、イギリス、イタリア、ロシア)
・アジア太平洋市場
- アジア太平洋のフルララネルAPI市場規模(種類別、用途別)
- 主要国別のフルララネルAPI市場規模(日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア)
・中南米市場
- 中南米のフルララネルAPI市場規模(種類別、用途別)
- 主要国別のフルララネルAPI市場規模(メキシコ、ブラジル、アルゼンチン)
・中東・アフリカ市場
- 中東・アフリカのフルララネルAPI市場規模(種類別、用途別)
- 主要国別のフルララネルAPI市場規模(トルコ、サウジアラビア)
・企業情報
HIKAL Ltd.、Nissan Chemical、HuBei Masteam Bio-tech、Shaanxi Dideu Group、Hunan Huateng Pharmaceutical、Hebei Lingding Biotechnology、Zhejiang Gihi Chemicals、Xiamen Sinoway Industrial
・産業チェーン及び販売チャネル分析
- フルララネルAPIの産業チェーン分析
- フルララネルAPIの原材料
- フルララネルAPIの生産プロセス
- フルララネルAPIの販売及びマーケティング
- フルララネルAPIの主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- フルララネルAPIの産業動向
- フルララネルAPIのマーケットドライバー
- フルララネルAPIの課題
- フルララネルAPIの阻害要因
・主な調査結果

Market Analysis and Insights: Global Fluralaner API Market
Due to the COVID-19 pandemic, the global Fluralaner API market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Min 95% accounting for % of the Fluralaner API global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Oral Drug segment is altered to an % CAGR throughout this forecast period.
China Fluralaner API market size is valued at US$ million in 2021, while the US and Europe Fluralaner API are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Fluralaner API landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Fluralaner API include HIKAL Ltd., Nissan Chemical, HuBei Masteam Bio-tech, Shaanxi Dideu Group, Hunan Huateng Pharmaceutical, Hebei Lingding Biotechnology, Zhejiang Gihi Chemicals and Xiamen Sinoway Industrial, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
In terms of production side, this report researches the Fluralaner API capacity, production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Fluralaner API by region (region level and country level), by company, by Type and by Application. from 2017 to 2022 and forecast to 2028.
Global Fluralaner API Scope and Segment
Fluralaner API market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Fluralaner API market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Min 95%
Min 98%
Segment by Application
Oral Drug
External Drug
By Company
HIKAL Ltd.
Nissan Chemical
HuBei Masteam Bio-tech
Shaanxi Dideu Group
Hunan Huateng Pharmaceutical
Hebei Lingding Biotechnology
Zhejiang Gihi Chemicals
Xiamen Sinoway Industrial
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

1 Study Coverage
1.1 Fluralaner API Product Introduction
1.2 Market by Type
1.2.1 Global Fluralaner API Market Size by Type, 2017 VS 2021 VS 2028
1.2.2 Min 95%
1.2.3 Min 98%
1.3 Market by Application
1.3.1 Global Fluralaner API Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Oral Drug
1.3.3 External Drug
1.4 Study Objectives
1.5 Years Considered
2 Global Fluralaner API Production
2.1 Global Fluralaner API Production Capacity (2017-2028)
2.2 Global Fluralaner API Production by Region: 2017 VS 2021 VS 2028
2.3 Global Fluralaner API Production by Region
2.3.1 Global Fluralaner API Historic Production by Region (2017-2022)
2.3.2 Global Fluralaner API Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Global Fluralaner API Sales in Volume & Value Estimates and Forecasts
3.1 Global Fluralaner API Sales Estimates and Forecasts 2017-2028
3.2 Global Fluralaner API Revenue Estimates and Forecasts 2017-2028
3.3 Global Fluralaner API Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Fluralaner API Sales by Region
3.4.1 Global Fluralaner API Sales by Region (2017-2022)
3.4.2 Global Sales Fluralaner API by Region (2023-2028)
3.5 Global Fluralaner API Revenue by Region
3.5.1 Global Fluralaner API Revenue by Region (2017-2022)
3.5.2 Global Fluralaner API Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Fluralaner API Production Capacity by Manufacturers
4.2 Global Fluralaner API Sales by Manufacturers
4.2.1 Global Fluralaner API Sales by Manufacturers (2017-2022)
4.2.2 Global Fluralaner API Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Fluralaner API in 2021
4.3 Global Fluralaner API Revenue by Manufacturers
4.3.1 Global Fluralaner API Revenue by Manufacturers (2017-2022)
4.3.2 Global Fluralaner API Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Fluralaner API Revenue in 2021
4.4 Global Fluralaner API Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Fluralaner API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Fluralaner API Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Fluralaner API Sales by Type
5.1.1 Global Fluralaner API Historical Sales by Type (2017-2022)
5.1.2 Global Fluralaner API Forecasted Sales by Type (2023-2028)
5.1.3 Global Fluralaner API Sales Market Share by Type (2017-2028)
5.2 Global Fluralaner API Revenue by Type
5.2.1 Global Fluralaner API Historical Revenue by Type (2017-2022)
5.2.2 Global Fluralaner API Forecasted Revenue by Type (2023-2028)
5.2.3 Global Fluralaner API Revenue Market Share by Type (2017-2028)
5.3 Global Fluralaner API Price by Type
5.3.1 Global Fluralaner API Price by Type (2017-2022)
5.3.2 Global Fluralaner API Price Forecast by Type (2023-2028)
6 Market Size by Application
6.1 Global Fluralaner API Sales by Application
6.1.1 Global Fluralaner API Historical Sales by Application (2017-2022)
6.1.2 Global Fluralaner API Forecasted Sales by Application (2023-2028)
6.1.3 Global Fluralaner API Sales Market Share by Application (2017-2028)
6.2 Global Fluralaner API Revenue by Application
6.2.1 Global Fluralaner API Historical Revenue by Application (2017-2022)
6.2.2 Global Fluralaner API Forecasted Revenue by Application (2023-2028)
6.2.3 Global Fluralaner API Revenue Market Share by Application (2017-2028)
6.3 Global Fluralaner API Price by Application
6.3.1 Global Fluralaner API Price by Application (2017-2022)
6.3.2 Global Fluralaner API Price Forecast by Application (2023-2028)
7 North America
7.1 North America Fluralaner API Market Size by Type
7.1.1 North America Fluralaner API Sales by Type (2017-2028)
7.1.2 North America Fluralaner API Revenue by Type (2017-2028)
7.2 North America Fluralaner API Market Size by Application
7.2.1 North America Fluralaner API Sales by Application (2017-2028)
7.2.2 North America Fluralaner API Revenue by Application (2017-2028)
7.3 North America Fluralaner API Sales by Country
7.3.1 North America Fluralaner API Sales by Country (2017-2028)
7.3.2 North America Fluralaner API Revenue by Country (2017-2028)
7.3.3 United States
7.3.4 Canada
8 Europe
8.1 Europe Fluralaner API Market Size by Type
8.1.1 Europe Fluralaner API Sales by Type (2017-2028)
8.1.2 Europe Fluralaner API Revenue by Type (2017-2028)
8.2 Europe Fluralaner API Market Size by Application
8.2.1 Europe Fluralaner API Sales by Application (2017-2028)
8.2.2 Europe Fluralaner API Revenue by Application (2017-2028)
8.3 Europe Fluralaner API Sales by Country
8.3.1 Europe Fluralaner API Sales by Country (2017-2028)
8.3.2 Europe Fluralaner API Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Fluralaner API Market Size by Type
9.1.1 Asia Pacific Fluralaner API Sales by Type (2017-2028)
9.1.2 Asia Pacific Fluralaner API Revenue by Type (2017-2028)
9.2 Asia Pacific Fluralaner API Market Size by Application
9.2.1 Asia Pacific Fluralaner API Sales by Application (2017-2028)
9.2.2 Asia Pacific Fluralaner API Revenue by Application (2017-2028)
9.3 Asia Pacific Fluralaner API Sales by Region
9.3.1 Asia Pacific Fluralaner API Sales by Region (2017-2028)
9.3.2 Asia Pacific Fluralaner API Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
10 Latin America
10.1 Latin America Fluralaner API Market Size by Type
10.1.1 Latin America Fluralaner API Sales by Type (2017-2028)
10.1.2 Latin America Fluralaner API Revenue by Type (2017-2028)
10.2 Latin America Fluralaner API Market Size by Application
10.2.1 Latin America Fluralaner API Sales by Application (2017-2028)
10.2.2 Latin America Fluralaner API Revenue by Application (2017-2028)
10.3 Latin America Fluralaner API Sales by Country
10.3.1 Latin America Fluralaner API Sales by Country (2017-2028)
10.3.2 Latin America Fluralaner API Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
10.3.6 Colombia
11 Middle East and Africa
11.1 Middle East and Africa Fluralaner API Market Size by Type
11.1.1 Middle East and Africa Fluralaner API Sales by Type (2017-2028)
11.1.2 Middle East and Africa Fluralaner API Revenue by Type (2017-2028)
11.2 Middle East and Africa Fluralaner API Market Size by Application
11.2.1 Middle East and Africa Fluralaner API Sales by Application (2017-2028)
11.2.2 Middle East and Africa Fluralaner API Revenue by Application (2017-2028)
11.3 Middle East and Africa Fluralaner API Sales by Country
11.3.1 Middle East and Africa Fluralaner API Sales by Country (2017-2028)
11.3.2 Middle East and Africa Fluralaner API Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE
12 Corporate Profiles
12.1 HIKAL Ltd.
12.1.1 HIKAL Ltd. Corporation Information
12.1.2 HIKAL Ltd. Overview
12.1.3 HIKAL Ltd. Fluralaner API Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 HIKAL Ltd. Fluralaner API Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 HIKAL Ltd. Recent Developments
12.2 Nissan Chemical
12.2.1 Nissan Chemical Corporation Information
12.2.2 Nissan Chemical Overview
12.2.3 Nissan Chemical Fluralaner API Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 Nissan Chemical Fluralaner API Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Nissan Chemical Recent Developments
12.3 HuBei Masteam Bio-tech
12.3.1 HuBei Masteam Bio-tech Corporation Information
12.3.2 HuBei Masteam Bio-tech Overview
12.3.3 HuBei Masteam Bio-tech Fluralaner API Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 HuBei Masteam Bio-tech Fluralaner API Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 HuBei Masteam Bio-tech Recent Developments
12.4 Shaanxi Dideu Group
12.4.1 Shaanxi Dideu Group Corporation Information
12.4.2 Shaanxi Dideu Group Overview
12.4.3 Shaanxi Dideu Group Fluralaner API Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 Shaanxi Dideu Group Fluralaner API Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Shaanxi Dideu Group Recent Developments
12.5 Hunan Huateng Pharmaceutical
12.5.1 Hunan Huateng Pharmaceutical Corporation Information
12.5.2 Hunan Huateng Pharmaceutical Overview
12.5.3 Hunan Huateng Pharmaceutical Fluralaner API Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 Hunan Huateng Pharmaceutical Fluralaner API Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Hunan Huateng Pharmaceutical Recent Developments
12.6 Hebei Lingding Biotechnology
12.6.1 Hebei Lingding Biotechnology Corporation Information
12.6.2 Hebei Lingding Biotechnology Overview
12.6.3 Hebei Lingding Biotechnology Fluralaner API Sales, Price, Revenue and Gross Margin (2017-2022)
12.6.4 Hebei Lingding Biotechnology Fluralaner API Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Hebei Lingding Biotechnology Recent Developments
12.7 Zhejiang Gihi Chemicals
12.7.1 Zhejiang Gihi Chemicals Corporation Information
12.7.2 Zhejiang Gihi Chemicals Overview
12.7.3 Zhejiang Gihi Chemicals Fluralaner API Sales, Price, Revenue and Gross Margin (2017-2022)
12.7.4 Zhejiang Gihi Chemicals Fluralaner API Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 Zhejiang Gihi Chemicals Recent Developments
12.8 Xiamen Sinoway Industrial
12.8.1 Xiamen Sinoway Industrial Corporation Information
12.8.2 Xiamen Sinoway Industrial Overview
12.8.3 Xiamen Sinoway Industrial Fluralaner API Sales, Price, Revenue and Gross Margin (2017-2022)
12.8.4 Xiamen Sinoway Industrial Fluralaner API Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 Xiamen Sinoway Industrial Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Fluralaner API Industry Chain Analysis
13.2 Fluralaner API Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Fluralaner API Production Mode & Process
13.4 Fluralaner API Sales and Marketing
13.4.1 Fluralaner API Sales Channels
13.4.2 Fluralaner API Distributors
13.5 Fluralaner API Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Fluralaner API Industry Trends
14.2 Fluralaner API Market Drivers
14.3 Fluralaner API Market Challenges
14.4 Fluralaner API Market Restraints
15 Key Finding in The Global Fluralaner API Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer